The TGA reported the decision resolved the "insufficient solutions" for people with some psychological sicknesses that did not respond to other treatment plans.This off-label use is technically legal, but a 2015 controversy more than clinics that allegedly skimped on psychiatric supervision and despatched patients residence to self-inject their ke